Charles River Laboratories | CRL - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Agilent USD 1.81B 49M 2026-03
Align Technology USD 1.1B 42.76M 2026-06
Bio-Rad Laboratories USD 517M 9.8M 2026-06
Bruker USD 184.9M 51.5M 2026-06
Cardinal Health USD 4.86B 919M 2026-06
Charles River Laboratories USD 192.02M 195K 2026-06
Cigna USD 6.3B 742M 2026-06
Concord Medical Services Hldg CNY 243.38M 85.1M 2023-06
CVS Health USD 11.33B 1.79B 2026-06
Danaher USD 4.35B 1.35B 2026-06
Dentsply International USD 239M 49M 2026-06
Elevance Health USD 10.23B 575M 2026-06
Humana USD 6.89B 1.94B 2026-06
Illumina USD 1.09B 329M 2026-03
Incyte USD 3.98B 33.45M 2026-06
Intrexon USD 9.34M 1.77M 2024-06
IQVIA Holdings USD 1.91B 38M 2026-06
Laboratory Of America USD 141.8M 839.3M 2026-06
Lakefront Biotherapeutics EUR 135.95M 69.15M 2026-06
Lonza CHF 719M 188M 2025-12
McKesson USD 5.16B 1.19B 2026-06
Merck EUR 2.74B 415M 2026-03
Mettler Toledo International USD 51.38M 9.19M 2026-06
Novartis USD 7.62B 739M 2026-06
Pfizer USD 976M 727M 2026-06
Quest Diagnostics USD 626M 233M 2026-06
Revvity USD 1.02B 162.62M 2026-06
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
United Therapeutics USD 1.8B 523.5M 2026-06
UnitedHealth USD 31.47B 239M 2026-06
Veradigm USD 492.6M 7.57M 2022-09
Waters USD 539M 77M 2026-06
West Pharmaceutical Services USD 435.8M 85.6M 2026-06